Reckitt Benckiser Launches Lemsip, a New Cold and Flu Remedy

Reckitt Benckiser has launched Lemsip, a new cold and flu medicine, on the Russian market. PR support for Lemsip (Reckitt Benckiser Healthcare) in Russia is provided by Fleishman-Hillard Vanguard.

Lemsip is an English medicine, which is an innovation on the Russian market, though it is the number one selling cold and flu brand in the UK. Lemsip relieves headaches, fevers, nasal congestion, body aches and pains, and sore throats. It provides relief after just 15-20 minutes, and its effect continues for four to six hours. In addition, Lemsip has a pleasant taste. An important feature of the medicine is that it does not cause drowsiness and, consequently, can be used all day long. Lemsip helps to relieve colds without causing the loss of concentration and attention that is so crucial for drivers and employees at certain jobs.

Lemsip is a nonprescription medicine that is used to relieve symptoms of colds and flus. It is manufactured by Reckitt Benckiser Healthcare.

Lemsip contains paracetamol and phenylephrine, which help to quickly relieve all the main symptoms of a cold or flu in the first stage of illness.  Lemsip comes in convenient packets and features multiple product lines for people with different categories of symptoms.

Different types of Lempsip will help to relieve different symptoms of cold. Lemsip Lemon and Lemsip Black Currant are for the first stages of cold and flu. Lemsip Max should be used for more advanced symptoms.

Reckitt Benckiser (RB) is a global leader, producing home, health, and personal care products.

The company was formed in 1999 by a merger between Reckitt & Colman and Benckiser N.V., which were founded in the first half of the nineteenth century. Today, Reckitt Benckiser is a multinational company, consisting of 27,000 people all over the world (in more than 180 countries). It has operations in over 60 countries.

Reckitt Benckiser has 19 world-known brands: Airwick, Bang, Calgon, Clearasil, Dettol, Durex, Finish, French’s, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Scholl, Strepsils, Vanish, Veet, and Woolite. They account for 69% of the company’s net revenues.

Reckitt Benckiser is listed on the UK stock exchange and is a FTSE top 25 company. Since 2000, Reckitt Benckiser’s sales volume has more than doubled and its market capitalization has grown more than four times.

Reckitt Benckiser first appeared in Russia in 1994 with the opening of a central office in Moscow. Currently, it has sales employees in more than 50 of Russia’s biggest cities and in the majority of CIS countries, including Ukraine, Georgia, Kazakhstan, Armenia and Azerbaijan.  In 2005, it opened a household chemical goods factory in Kline. Today, there are more than 800 employees who are working in RB Russia/CIS.